Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-05-21 | Reverse | 1:10 |
| 2026-03-25 | Reverse | 1:5 |
| 2025-06-13 | Reverse | 1:85 |
| 2024-09-24 | Reverse | 1:40 |
Onconetix, Inc. is a Cincinnati-based biotech firm developing FDA-approved therapies like Entadfi and innovative vaccines for infectious diseases, including pneumonia, flu, norovirus, Marburg, and monkeypox.

Following its acquisition of Realbotix LLC, Onconetix now offers customizable AI-powered humanoid robots for commercial use in healthcare, education, hospitality, and other industries, marking a strategic shift into advanced robotics.
| Icon | PRODUCT | Q1-2024 | Q2-2024 | Q3-2024 | Q2-2025 |
|---|---|---|---|---|---|
![]() | Product | $100K | $100K | $100K | $100K |
| Map | REGION | Q1-2025 | Q2-2025 | Q4-2025 | Q2-2026 |
|---|---|---|---|---|---|
![]() | European Union | $94.38K | $104.21K ▲ | $597.99K ▲ | — |
![]() | SWITZERLAND | — | — | — | $10.32K |
Overall rating: B
| PEER | PRICE | |
|---|---|---|
INDP | $1.14 | COMPARE |
JSPR | $0.70 | COMPARE |
REVB | $1.05 | COMPARE |
PTIX | $0.98 | COMPARE |
ENVB | $1.37 | COMPARE |
SPRC | $6.58 | COMPARE |
SLXN | $0.36 | COMPARE |
SCNI | $2.51 | COMPARE |